FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

9727111000001100: Amphotericin (lipid formulation) 50mg powder for solution for injection vials 1 vial (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 17-Oct 2012. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    31389501000001115 Amphotericin (lipid formulation) 50mg powder for solution for injection vials 1 vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
    52359601000001117 Amphotericin B (lipid formulation) 50mg powder for solution for infusion vials 1 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Amphotericin (lipid formulation) 50mg powder for solution for injection vials 1 vial Is a Virtual medicinal product pack false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg powder for solution for injection vials 1 vial Is pack of Amphotericin (lipid formulation) 50mg powder for solution for injection vials false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg powder for solution for injection vials 1 vial Has active ingredient Amphotericin false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg powder for solution for injection vials 1 vial VMP prescribing status (attribute) Not recommended to prescribe as a VMP false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg powder for solution for injection vials 1 vial VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg powder for solution for injection vials 1 vial Has manufactured dose form Powder for conventional release solution for injection false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg powder for solution for injection vials 1 vial Has VMP Amphotericin (lipid formulation) 50mg powder for solution for injection vials false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg powder for solution for injection vials 1 vial Has specific active ingredient Amphotericin false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg powder for solution for injection vials 1 vial Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
    Amphotericin (lipid formulation) 50mg powder for solution for injection vials 1 vial VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Amphocil 50mg powder for solution for injection vials (Cambridge Laboratories) 1 vial Is a False Amphotericin (lipid formulation) 50mg powder for solution for injection vials 1 vial Inferred relationship Existential restriction modifier
    AmBisome 50mg powder for solution for infusion vials (Gilead Sciences Ltd) 1 vial Is a False Amphotericin (lipid formulation) 50mg powder for solution for injection vials 1 vial Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start